Previous 10 | Next 10 |
On Friday, investors were refusing the pill that is generic-drug specialist Lannett (NYSE: LCI) . The company's shares took a painful hit, sinking by 13% after the company got the toss from a high-profile stock index. After market close Thursday S&P Dow Jones Indices, the co...
Gainers: SemiLEDs (LEDS) +49%.Vertex Energy (VTNR) +45%.Organovo (ONVO) +28%.eMagin (EMAN) +24%.Mannatech (MTEX) +21%.Welbilt (WBT) +21%.Yext (YEXT) +19%.MoSys (MOSY) +16%.Embotelladora Andina (AKO-B) +13%.Iterum Therapeutics (ITRM) +17%.Losers: 1847 Goedeker (GOED) -70%.M...
Gainers: Organovo (ONVO) +24%, Iterum Therapeutics (ITRM) +16%, Adagene (ADAG) +14%, Freeline Therapeutics (FRLN) +12%, 180 Life Sciences (ATNF) +12%.Losers: Provention Bio (PRVB) -22%, Eton Pharmaceuticals (ETON) -13%, Lannett (LCI) -12%...
Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service Properties Trust to Join S&P SmallCap 600 Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service Properties Trust to Join S&P SmallCap 600 PR Newswire ...
Lannett Company (LCI) is 5.5% lower after hours, part of a ripple effect that has it being removed from the S&P SmallCap 600 index. Organon & Co. (OGN) is being added to the S&P 500 as part of its spin-off from Merck (MRK) - which will remain in the S&P 100 and S&P 500 aft...
Image source: The Motley Fool. Lannett Company, Inc (NYSE: LCI) Q1 2021 Earnings Call May 5, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lannett Company, Inc (LCI) Q1 2021 Earnings Call Transcript
Lannett Company, Inc. (LCI) Q3 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Robert Jaffe - Investor Relations, Robert Jaffe Co., LLC Sam Israel - General Counsel Tim Crew - Chief Executive Officer John Kozlowski - Chief Financial Officer Maureen Cavanaugh - Chief ...
Lannett (LCI): Q3 Non-GAAP EPS of $0.02 beats by $0.07; GAAP EPS of -$0.18 misses by $0.01.Revenue of $112.37M (-22.2% Y/Y) misses by $3.74M.Press Release For further details see: Lannett EPS beats by $0.07, misses on revenue
Lannett Announces Fiscal 2021 Third-Quarter Financial Results Q3 Business and Financial Highlights: - Net Sales Were $112 Million - Adjusted Gross Margin, Adjusted Profitability Better than Expected - Cash Significantly Increased to More Than $80 Million - Full-Y...
Lannett (NYSE:LCI) is scheduled to announce FQ3 earnings results on Wednesday, May 5th, after market close.The consensus EPS Estimate is -$0.05 (-118.5% Y/Y) and the consensus Revenue Estimate is $116.11M (-19.6% Y/Y).Over the last 2 years, LCI has beaten EPS estimates 50% of the time and has...
News, Short Squeeze, Breakout and More Instantly...
Lannett Co Inc Company Name:
LCI Stock Symbol:
NYSE Market:
NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS PR Newswire Company Expects No Impact on Operations Negotiations with Key Secured Creditors Progressing Toward a Balance Sheet Strengthening Transaction ...
LANNETT SHARES UPDATE PR Newswire Announces Positive Results from Pivotal Clinical Insulin Trial that Demonstrates Biosimilarity to Reference Product Productive Conversations with Key Secured Creditors Toward a Balance Sheet Strengthening, Recapitalization or Res...